Clinical trialNCT04472585UnknownPhase 1/PHASE2Interventional

Efficacy of Subcutaneous Ivermectin With or Without Zinc in COVID-19 Patients

SponsorSohaib AshrafEnrollment180COVIDCoronavirus InfectionSars-CoV2

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

To measure the effect of Ivermectin (sub-cutaneous) with or without zinc in treating the COVID-19 patients to clear viral load of SARS-CoV-2 along with reduction in severity of symptoms and length of hospitalization of patients with COVID-19.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Moneeb Ashraf, MBBS
Mayo Hospital, Pakistan
Principal Investigator
clinicaltrials.gov ↗
Muhammad Ashraf, PhD
University of Veterinary & Animal Sciences, Lahore, Pakistan
Study Chair
clinicaltrials.gov ↗
Shoaib Ashraf, PhD
Harvard University Boston, USA
Study Director
clinicaltrials.gov ↗
Sohaib Ashraf, MBBS
Shaikh Zayed Medical Complex, Pakistan
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Pakistan

Ali Clinic
Lahore, MA, Pakistan
Recruiting
Shaikh Zayed Hospital
Lahore, Punjab Province, Pakistan
Muhammad Ahmad Imran, MBBS
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Ivermectin →Placebo empty capsuleZinc

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 14 Nov 2020
Primary completion: 15 Aug 2021
Completion: 30 Oct 2021
Last update posted: 17 Feb 2021
Registered enrollment: 180
Registry id: NCT04472585

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.